NCT05152927 2025-12-15
Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
University of California, San Francisco
Phase NA Completed
Clinical Trials
13 trialsNCT05022641 2025-08-27
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
University of Michigan
Phase NA Completed
NCT06779760 2025-01-17
NIRAF MIVAP
Aristotle University Of Thessaloniki
Completed
NCT01409798 2024-09-26
The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
University of Nebraska
Completed
NCT04299425 2024-05-13
NIRAF
Vanderbilt-Ingram Cancer Center
Phase NA Completed
NCT04608253 2024-04-16
A Retrospective Analysis of the Diagnostic Performance of 11C-choline PET/CT in Primary Hyperparathyroidism
University Medical Center Groningen
Completed
NCT04344886 2022-12-07
Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery
University Hospital Ostrava
Phase NA Completed
NCT03011736 2021-08-12
Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism
Roswell Park Cancer Institute
Phase NA Completed
NCT03280264 2021-05-27
Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Phase 3 Completed
NCT03027557 2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3 Completed
NCT01460030 2017-03-03
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Phase 3 Completed
NCT01060982 2014-05-06
Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure
Theraclion
Phase NA Completed
NCT00037518 2013-05-08
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
Amgen
Phase 4 Completed